Ganymede Bio, a Palo Alto, CA-based cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, raised $12.75M in Series A funding.
The round was led by Caffeinated Capital.
The company intends to use the funds to support the ongoing development of its cloud-native data platform, cloud IDE, and self-service tooling.
Ganymede is a cloud infrastructure provider purpose-built for the life sciences and manufacturing industries. Its Lab-as-Code technology integrates physical lab instruments, apps, data pipelines, and third-party partners like CROs and CDMOs together in a single cloud data layer. Ganymede accelerates time to innovation by giving scientists the ability to automate the world around them using cloud-controlled data flows.
Founded in 2022, the company has exceeded $1 million in revenue commitments, with clients ranging from early-stage biotechs to large, established biopharmaceutical companies.
FinSMEs
20/12/2022